TY - JOUR
T1 - γδ T cells provide an early source of interferon γ in tumor immunity
AU - Gao, Yunfei
AU - Yang, Wancai
AU - Pan, Meng
AU - Scully, Eileen
AU - Girardi, Michael
AU - Augenlicht, Leonard H.
AU - Craft, Joe
AU - Yin, Zhinan
PY - 2003/8/4
Y1 - 2003/8/4
N2 - Interferon (IFN)-γ is necessary for tumor immunity, however, its initial cellular source is unknown. Because γδ T cells primarily produce this cytokine upon activation, we hypothesized that they would provide an important early source of IFN-γ in tumor immunosurveillance. To address this hypothesis, we first demonstrated that γδ T cell-deficient mice had a significantly higher incidence of tumor development after challenge with a chemical carcinogen methylcholanthrene (MCA) or inoculation with the melanoma cell line B16. In wild-type mice, γδ T cells were recruited to the site of tumor as early as day 3 after inoculation, followed by αβ T cells at day 5. We then used bone marrow chimeras and fetal liver reconstitutions to create mice with an intact γδ T cell repertoire but one that was specifically deficient in the capacity to produce IFN-γ. Such mice had a higher incidence of tumor development, induced either with MCA or by inoculation of B16 melanoma cells, compared with mice with IFN-γ-competent γδ T cells. Moreover, genetic deficiency of γδ T cells resulted in impaired IFN-γ production by tumor antigen-triggered αβ T cell upon immunization with tumor lysate. These results demonstrate that γδ T cells can play a necessary role in tumor immunity through provision of an early source of IFN-γ that in turn may regulate the function of tumor-triggered αβ T cells.
AB - Interferon (IFN)-γ is necessary for tumor immunity, however, its initial cellular source is unknown. Because γδ T cells primarily produce this cytokine upon activation, we hypothesized that they would provide an important early source of IFN-γ in tumor immunosurveillance. To address this hypothesis, we first demonstrated that γδ T cell-deficient mice had a significantly higher incidence of tumor development after challenge with a chemical carcinogen methylcholanthrene (MCA) or inoculation with the melanoma cell line B16. In wild-type mice, γδ T cells were recruited to the site of tumor as early as day 3 after inoculation, followed by αβ T cells at day 5. We then used bone marrow chimeras and fetal liver reconstitutions to create mice with an intact γδ T cell repertoire but one that was specifically deficient in the capacity to produce IFN-γ. Such mice had a higher incidence of tumor development, induced either with MCA or by inoculation of B16 melanoma cells, compared with mice with IFN-γ-competent γδ T cells. Moreover, genetic deficiency of γδ T cells resulted in impaired IFN-γ production by tumor antigen-triggered αβ T cell upon immunization with tumor lysate. These results demonstrate that γδ T cells can play a necessary role in tumor immunity through provision of an early source of IFN-γ that in turn may regulate the function of tumor-triggered αβ T cells.
KW - Cytokines
KW - Immune regulation
KW - Immunosurveillance
KW - Tumor immunosurveillance
UR - http://www.scopus.com/inward/record.url?scp=0042123726&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0042123726&partnerID=8YFLogxK
U2 - 10.1084/jem.20030584
DO - 10.1084/jem.20030584
M3 - Article
C2 - 12900519
AN - SCOPUS:0042123726
SN - 0022-1007
VL - 198
SP - 433
EP - 442
JO - Journal of Experimental Medicine
JF - Journal of Experimental Medicine
IS - 3
ER -